Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenue:        
Revenue $ 5,860,061 $ 2,907,712 $ 10,773,393 $ 4,079,464
Cost of Revenues 3,206,435 1,972,586 5,887,250 2,730,459
Gross Profit 2,653,626 935,126 4,886,143 1,349,005
Operating Expenses:        
Selling, general and administration 7,546,570 3,951,595 15,485,628 7,087,255
Research and development 2,335 2,440 27,508 3,592
Depreciation and amortization 557,393 401,929 989,443 579,474
Total Operating Expenses 8,106,298 4,355,964 16,502,579 7,670,321
Operating Loss (5,452,672) (3,420,838) (11,616,436) (6,321,316)
Other Income and (Expense):        
Interest 28,169 (23,011) 38,069 (96,015)
Accretion of debt discount (70,754) (116,711)
Other income 49,675 19,542 41,141 19,542
Total Other Income (Expense) 77,844 (74,223) 79,210 (193,184)
Net Loss (5,374,828) (3,495,061) (11,537,226) (6,514,500)
Deemed dividend 855,541 314,100 3,863,241 1,244,400
Net loss attributable to common shareholders $ (6,230,369) $ (3,809,161) $ (15,400,467) $ (7,758,900)
Net loss per share: Basic and Diluted $ (0.22) $ (4.77) $ (0.71) $ (13.87)
Weighted average common shares: Basic and Diluted 27,912,957 798,608 21,742,677 559,400